NUVIMAFLU Trademark

Trademark Overview

On Thursday, June 24, 2021, a trademark application was filed for NUVIMAFLU with the United States Patent and Trademark Office. The USPTO has given the NUVIMAFLU trademark a serial number of 90792531. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, November 27, 2023. This trademark is owned by Novavax, Inc.. The NUVIMAFLU trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of vaccines, and clinical trials and post-market trials related to vaccines; consulting services in the field of research and development of vaccines; vaccine research and development
nuvimaflu

General Information

Serial Number90792531
Word MarkNUVIMAFLU
Filing DateThursday, June 24, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, November 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of vaccines, and clinical trials and post-market trials related to vaccines; consulting services in the field of research and development of vaccines; vaccine research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU EXTENSION 4 GRANTED
Monday, November 27, 2023SOU EXTENSION 4 FILED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2023SOU EXTENSION 3 GRANTED
Thursday, April 13, 2023SOU EXTENSION 3 FILED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2022SOU EXTENSION 2 GRANTED
Friday, December 9, 2022SOU EXTENSION 2 FILED
Friday, December 9, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2022SOU EXTENSION 1 GRANTED
Monday, July 25, 2022SOU EXTENSION 1 FILED
Monday, July 25, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021ASSIGNED TO EXAMINER
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 28, 2021NEW APPLICATION ENTERED

Related Keywords

nuvimaflu vaccines research field development trials related consulting services vaccine market